Institute of Molecular Biology & Translational Medicine, Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu, China.
Acta Neurol Scand. 2014 Feb;129(2):71-9. doi: 10.1111/ane.12201. Epub 2013 Nov 20.
To evaluate the existing prospective observational studies on the morality risk among Parkinson's disease (PD) patients and determine the overall risk ratio (RR) of mortality by conducting a meta-analysis and systematic review. Original articles published in English were searched in PubMed and Embase databases prior to March 2013. Only prospective observational studies providing adjusted risk estimates related to PD and future mortality were considered eligible. Pooled adjusted RR and 95% confidence interval (CI) were computed either by fixed-effects models or by random-effects models. Eight studies with 72,833 participants were identified and analysed. In the pooled analyses, patients with PD had a greater risk of all-cause mortality (RR = 2.22; 95% CI: 1.78-2.77). Subgroup analyses based on the design, gender, follow-up duration and sample size showed that a consistent positive association between PD and the mortality risk in each subgroup. However, no statistical significance was found for the baseline age <65 years (RR = 1.42; 95% CI: 0.72-2.77). PD patients with dementia had particularly high mortality risks (RR = 3.78; 95% CI: 2.06-6.92). This meta-analysis indicated that among patients with PD, the all-cause mortality increased by 2.22-fold compared with the general population. PD patients with dementia particularly had higher risks of mortality.
评估现有帕金森病(PD)患者道德风险的前瞻性观察研究,通过荟萃分析和系统评价确定死亡率的总体风险比(RR)。
检索 2013 年 3 月前在 PubMed 和 Embase 数据库发表的英文原始文献,仅纳入提供与 PD 和未来死亡率相关的调整风险估计值的前瞻性观察研究。采用固定效应模型或随机效应模型计算汇总调整 RR 和 95%置信区间(CI)。
共纳入 8 项研究,包含 72833 例参与者。汇总分析显示,PD 患者全因死亡率较高(RR=2.22,95%CI:1.782.77)。基于设计、性别、随访时间和样本量的亚组分析显示,PD 与死亡率风险之间存在一致的正相关关系。然而,基线年龄<65 岁亚组(RR=1.42,95%CI:0.722.77)差异无统计学意义。伴有痴呆的 PD 患者死亡率风险尤其高(RR=3.78,95%CI:2.06~6.92)。
PD 患者全因死亡率较一般人群增加 2.22 倍,伴有痴呆的 PD 患者死亡率风险更高。